Ghiath M. Sukhtian, Director, 10% Owner at Outlook Therapeutics, Inc. (OTLK), bought 16,000,000 shares at $1.25 ($20.0M) on 2021-11-29, disclosed to the SEC on 2021-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |